Genetic Evidence of Cross-Border Plasmodium vivax Spread in a Malaria Pre-elimination Region of South Asia
Open Access
- 15 May 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , e671-e680
Abstract
Background: Plasmodium vivax is the predominant cause of malaria in South Asia. P. vivax cases have fallen over the past decade, but cross-border transmission remains a major challenge to elimination. Genetic data can generate valuable insights into transmission; however, until now, only low-resolution data have been available from Nepal, Bhutan and Bangladesh. We piloted high-resolution genotyping using a new microhaplotype (multiallelic) assay to monitor P. vivax transmission across borders. Methods: Genotyping was conducted using the 93-microhaplotype vivaxGEN panel on P. vivax parasites collected from patients enrolled in clinical trials in Bangladesh, Bhutan, and Nepal between 2013 and 2023. These data were compared with open-access microhaplotype and genomic data derived from Afghanistan, India, and Pakistan between 2014 and 2024. Complexity and relatedness (identity by descent [IBD]) were determined within and between countries. Results: High-quality genotyping data were generated for Nepal (n = 19), Bhutan (n = 27), and Bangladesh (n = 35); comparative data were sourced from Afghanistan (n = 159), India (n = 24), and Pakistan (n = 213). High-complexity infections were observed in 27.04% (43/159) of isolates from Afghanistan, 16.43% (35/213) from Pakistan, and 28.57% (10/35) from Bangladesh. Low prevalence of high-complexity infections was observed in Bhutan (3.70%; 1/27) and Nepal (5.26%; 1/19), suggesting lower superinfection or co-infection. Country-wide IBD analyses revealed 3 genetic clusters partitioning Bangladesh and Bhutan (partial) from the remaining countries. There were 2 subpopulations in Bhutan, which separated local and cross-border imported cases. Conclusions: Our results highlight the use of regional high-resolution genetic data to enhance monitoring of transmission intensity and cross-border importations.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-043618)
- National Health and Medical Research Council (GNT2025377)
- Menzies School of Health Research
- Australian Centre of Research Excellence in Malaria Elimination (1134989)
This publication has 32 references indexed in Scilit:
- Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialThe Lancet Infectious Diseases, 2026
- Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineagesNature Communications, 2025
- Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong SubregionNature Communications, 2025
- MOIRE: a software package for the estimation of allele frequencies and effective multiplicity of infection from polyallelic dataBioinformatics, 2024
- Molecular markers for malaria genetic epidemiology: progress and pitfallsTrends in Parasitology, 2023
- Hidden Biomass of Intact Malaria Parasites in the Human SpleenNew England Journal of Medicine, 2021
- Distinctive genetic structure and selection patterns in Plasmodium vivax from South Asia and East AfricaNature Communications, 2021
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trialThe Lancet, 2019
- Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamicsNature Communications, 2018
- Dissecting malaria biology and epidemiology using population genetics and genomicsInternational Journal for Parasitology, 2017